Clinical Trial Update: Study of Memantine to Treat Huntington's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating memantine for Huntington's disease has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Jody Corey-Bloom, MD, PhD | Conditions: Huntington's Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-01-05